U.S. Markets closed

Tetraphase Pharmaceuticals, Inc. (TTPH)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.55-0.29 (-4.24%)
At close: 4:00PM EDT
People also watch
CEMPCMRXPTCTESPRZFGN
Full screen
Previous Close6.84
Open6.80
Bid5.63 x 100
Ask7.95 x 200
Day's Range6.51 - 6.85
52 Week Range3.11 - 9.93
Volume1,060,780
Avg. Volume1,274,484
Market Cap334.4M
Beta2.97
PE Ratio (TTM)-2.33
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube23 days ago

    ETFs with exposure to Tetraphase Pharmaceuticals, Inc. : September 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Tetraphase Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to TTPH-US. Comparing the performance and risk of Tetraphase Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Tetraphase Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : TTPH-US : August 31, 2017
    Capital Cube24 days ago

    Tetraphase Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : TTPH-US : August 31, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Tetraphase Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cubelast month

    Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Tetraphase Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Tetraphase Pharmaceuticals, Inc. – NovaBay Pharmaceuticals, Inc., Pfizer Inc., Achaogen, Inc. and Merck & Co., Inc. (NBY-US, PFE-US, AKAO-US and MRK-US) that have also reported for this period. ... Read more (Read more...)